🇺🇸 FDA
Patent

US 9040721

Halogenated compounds for Photodynamic therapy

granted A61KA61K31/403A61K31/404

Quick answer

US patent 9040721 (Halogenated compounds for Photodynamic therapy) held by NANOQUANTUM SCIENCES, INC. expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NANOQUANTUM SCIENCES, INC.
Grant date
Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/403, A61K31/404, A61K31/438, A61K41/0057